Sun Pharma Q3 profit falls 5% to Rs 1472 cr on higher tax cost
Sun Pharma 's third quarter profit fell 4.7 percent year-on-year to Rs 1,472 crore, impacted by higher tax cost. Revenue increased 11.1 percent to Rs 7,912.6 crore compared with year-ago period.
Operating profit margin stood at 31 percent in Q3FY17 against 31.5 percent in Q3FY16. Tax expenses during the quarter jumped significantly to Rs 373 from Rs 89 crore on year-on-year basis.
Technical Levels for Sunpharma
Support at 640 and Resistance at 665
Break and sustain above 665 will take it to 675—690 and then to 705+ mark , else could touch its support level of 640.
Looks weak below 640 only.
More will update soon!!
